1–2 of 2 results for Andrew J. Barkmeier
Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Andrew J. Barkmeier, MD
Updates from the Field
2024
Diabetic Retinopathy Telemedicine Outcomes With Artificial Intelligence-Based Image Analysis, Reflex Dilation, and Image Overread Protocol
Annual Meeting Talks
2021